This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demeter, L. M.
Right arrow Articles by Hammer, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demeter, L. M.
Right arrow Articles by Hammer, S. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2002, p. 2089-2094, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2089-2094.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Detection of Replication-Competent Human Immunodeficiency Virus Type 1 (HIV-1) in Cultures from Patients with Levels of HIV-1 RNA in Plasma Suppressed to Less Than 500 or 50 Copies Per Milliliter{dagger}

Lisa M. Demeter,1* Ronald J. Bosch,2 Robert W. Coombs,3 Susan Fiscus,4 James Bremer,5 Victoria A. Johnson,6 Alejo Erice,7 J. Brooks Jackson,8 Stephen A. Spector,9 Kathleen M. Squires,6,{dagger} Margaret A. Fischl,10 Michael D. Hughes,2 and Scott M. Hammer11

University of Rochester School of Medicine and Dentistry, Rochester,1 Columbia University, New York,11 New York; Harvard School of Public Health, Boston, Massachusetts,2 University of Washington, Seattle, Washington,3 University of North Carolina, Chapel Hill, North Carolina,4 Rush Medical College, Chicago, Illinois,5 University of Alabama at Birmingham School of Medicine and Birmingham Veterans Affairs Medical Center, Birmingham, Alabama,6 University of Minnesota, Minneapolis, Minnesota,7 Johns Hopkins University, Baltimore, Maryland,8 University of California at San Diego, San Diego, California,9 University of Miami School of Medicine, Miami, Florida,10

Received 17 August 2001/ Returned for modification 29 November 2001/ Accepted 12 March 2002

We determined the frequency with which human immunodeficiency virus (HIV) peripheral blood mononuclear cell cultures convert from positive to negative in subjects enrolled in a substudy of AIDS Clinical Trials Group (ACTG) 320, which compared the efficacy of treatment with a combination of indinavir, zidovudine, and lamivudine (indinavir arm) to that of a combination of zidovudine and lamivudine (dual-nucleoside arm). All subjects included for study had positive baseline HIV cultures. Cultures were performed in real time with 107 fresh patient peripheral blood mononuclear cells, using the ACTG consensus method. We found lower rates of positive HIV cultures in the indinavir treatment arm than in the dual-nucleoside treatment arm (64 versus 96% at week 24, P < 0.001). Within the indinavir arm of the study, we found that positive cultures were less likely to occur in samples with a plasma HIV type 1 (HIV-1) RNA level of <500 copies/ml than in those with a level of >=500 copies/ml (44 versus 90%, P < 0.001). In addition, HIV cultures from samples with HIV-1 RNA levels of >=500 copies/ml turned positive 8.5 days earlier, on average, than those from samples with levels of <500 copies/ml (P < 0.001). However, 38% of samples with plasma RNA levels of <50 copies/ml still were positive for HIV by culture. Thus, the rates of HIV isolation by standard culture procedures decrease as the plasma viral load decreases below 1,000 copies/ml; however, HIV isolates were still obtained from a substantial proportion of subjects with RNA levels of <50 copies/ml. The delay in the time required for HIV cultures to turn positive should be considered when attempting to obtain an HIV isolate from patients with suppression of plasma viral load.

* Corresponding author. Mailing address: University of Rochester Infectious Diseases Unit, 601 Elmwood Ave., Box 689, Rochester, NY 14642. Phone: (585) 275-4764. Fax: (585) 442-9328. E-mail: Lisa_Demeter{at}urmc.rochester.edu.

{dagger} AIDS Clinical Trials Group Protocol 867.

Journal of Clinical Microbiology, June 2002, p. 2089-2094, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2089-2094.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hosoya, N., Su, Z., Wilkin, T., Gulick, R. M., Flexner, C., Hughes, M. D., Skolnik, P. R., Giguel, F., Greaves, W. L., Coakley, E., Kuritzkes, D. R. (2009). Assessing Human Immunodeficiency Virus Type 1 Tropism: Comparison of Assays Using Replication-Competent Virus versus Plasma-Derived Pseudotyped Virions. J. Clin. Microbiol. 47: 2604-2606 [Abstract] [Full Text]  
  • Stewart, M., Desport, M., Hartaningsih, N., Wilcox, G. (2005). TaqMan Real-Time Reverse Transcription-PCR and JDVp26 Antigen Capture Enzyme-Linked Immunosorbent Assay To Quantify Jembrana Disease Virus Load during the Acute Phase of In Vivo Infection. J. Clin. Microbiol. 43: 5574-5580 [Abstract] [Full Text]  
  • Crowe, S., Zhu, T., Muller, W. A. (2003). The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol. 74: 635-641 [Abstract] [Full Text]  
  • Cummins, J. E. Jr., Villanueva, J. M., Evans-Strickfaden, T., Sesay, S. M., Abner, S. R., Bush, T. J., Green, T. A., Lennox, J. L., Wright, T., Folks, T. M., Hart, C. E., Dezzutti, C. S. (2003). Detection of Infectious Human Immunodeficiency Virus Type 1 in Female Genital Secretions by a Short-Term Culture Method. J. Clin. Microbiol. 41: 4081-4088 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»